Cagrilintide is a long-acting amylin analogue research peptide studied in laboratory settings for its potential effects on appetite regulation pathways, energy homeostasis, and metabolic signaling. This compound is of significant scientific interest in research focused on body weight regulation and glucose metabolism studies. When studied in combination with GLP-1 receptor agonists, Cagrilintide has shown particular interest in metabolic research settings. Each vial contains 10MG of lyophilized Cagrilintide with purity ≥ 99%, verified by third-party HPLC testing. Intended strictly for research and laboratory use only. Not for human consumption.